Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org
Washington, DC
ARM commends the Biden administration for nominating Dr. Robert Califf as FDA commissioner at a momentous time for public health and the development of innovative technologies.
Washington, DC
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today announced the election of its 2022 Officers, Executive Committee, and Board of Directors.
Washington, DC
ARM commends FDA for, among other things, the inclusion of two priority elements supported by ARM in the agency’s Prescription Drug User Fee Act VII (PDUFA) commitment letter that will advance cell and gene therapy.
Washington, DC
The regenerative medicine and advanced therapies sector completed its best-ever six-month period of financing, raising $14.1B from January through June and reaching 71% of the record amount raised in all of 2020, according to the Alliance for Regenerative Medicine’s (ARM) H1 2021 Report released today.
